Workshop E – Optimizing Clinical Trial Endpoints in Neuro-Oncology Trials, Glioblastoma Clinical Trials: Utilizing Biomarkers, Endpoints, & Models for Success
Time: 2:00 pm
day: Pre-Conference Workshop Day
Details:
Many promising therapies for glioblastoma face challenges when moving from preclinical to clinical trials, particularly with the complexity of combination treatments. Designing effective trials is crucial, and this workshop will address strategies for overcoming these obstacles.
Key Discussion Points:
- Combining cell and gene therapies with standard-of-care treatment of primary disease
- Rethinking cell therapy approaches beyond simply response to providing a meaningful extension of length and quality of life
- Overcoming regulatory and funding barriers to early intervention
